Cancer Family
Malignant Thoracic Neoplasm
CI-CAN-00000256Explore in graph →
2,775 active trials51 approved drugs626 evidence items
- NCIt
- C3576
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000256Explore in graph →
Clinical trials
11,499 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,528)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01279967 | A Clinical Trial of ADI-PEG 20TM in Patients With Malignant Pleural Mesothelioma(ADAM) | unknown | Phase 2 | 70 | Barts & The London NHS TrustOTHER | 1 | Nov 20, 2014 | clinicaltrials |
| NCT02288026 | Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung Cancer | unknown | — | 630 | Capital Medical UniversityOTHER | 1 | Nov 11, 2014 |
| clinicaltrials |
| NCT02285660 | Evaluation of 4D-contrast Enhanced PET-CT in Tumour Volume Definition | unknown | N/A | — | The Leeds Teaching Hospitals NHS TrustOTHER | 1 | Nov 7, 2014 | clinicaltrials |
| NCT02283476 | The Comparative Study on Rh-Endostatin (Endostar®) Continuous Intravenous Infusion and Routine i.v in Combination With GP Regimens for Phase III B/IV Squamous Cell Lung Cancer and Biological Markers Exploration. | unknown | Phase 3 | 200 | Jiangsu Simcere Pharmaceutical Co., Ltd.INDUSTRY | 1 | Nov 6, 2014 | clinicaltrials |
| NCT02281708 | Multicenter Randomized Controlled Trial Adjuvant Chemotherapy vs Observation in pStage Ib Lung Adenocarcinoma | unknown | Phase 3 | 1,012 | Seoul National University HospitalOTHER | 1 | Nov 3, 2014 | clinicaltrials |
| NCT02272127 | Study of Chemotherapy Plus Icotinib to Treat EGFR Mutation-positive Non-small-cell Lung Cancer | unknown | Phase 2 | 100 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Oct 22, 2014 | clinicaltrials |
| NCT02262897 | The Efficacy and Safety of Nab-paclitaxel in Pretreated Patients With Extensive Disease of Small Cell Lung Cancer | unknown | Phase 2 | 40 | Tongji UniversityOTHER | 1 | Oct 13, 2014 | clinicaltrials |
| NCT01426841 | Pilot Project of Adaptive Thoracic Radiotherapy for Small Cell Lung Cancer | unknown | Phase 1 | 10 | AHS Cancer Control AlbertaOTHER | 1 | Oct 2, 2014 | clinicaltrials |
| NCT01624051 | A Study Comparing Chemotherapy Dosing Based on Either Standard Body Surface Area or Lean Body Mass in Patients With Advanced Lung Cancer | unknown | Phase 2 | 144 | AHS Cancer Control AlbertaOTHER | 1 | Sep 30, 2014 | clinicaltrials |
| NCT01424709 | Individualized Chemotherapy Based on BRCA1 and RRM1 mRNA for Advanced Non-small Cell Lung Cancer (NSCLC)(BRAVO) | unknown | Phase 2 | 120 | Tongji UniversityOTHER | 1 | Sep 25, 2014 | clinicaltrials |
| NCT02247713 | An International Study on the Use of PET/CT in Radiotherapy Planning in Low and Middle Income Countries(PERTAIN) | unknown | — | 520 | The Netherlands Cancer InstituteOTHER | 0 | Sep 25, 2014 | clinicaltrials |
| NCT02239432 | Telomere Biology in Early Adenocarcinoma of the Lung | unknown | — | 100 | Meir Medical CenterOTHER | 1 | Sep 12, 2014 | clinicaltrials |
| NCT02224547 | Risk-adapted Stereotactic Body Radiotherapy for Early Non-Small Cell Lung Cancer Using the VERO Stereotactic Body Radio Therapy System | unknown | Phase 2 | 58 | Universitair Ziekenhuis BrusselOTHER | 1 | Sep 9, 2014 | clinicaltrials |
| NCT02215356 | Icotinib With Concurrent Radiotherapy Versus Chemotherapy With Concurrent Radiotherapy in Non-small Cell Lung Cancer | unknown | Phase 2 | 120 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Aug 13, 2014 | clinicaltrials |
| NCT02191059 | Phase II Clinical Study of Intermittent High Dose of Icotinib in Combination With Docetaxel to Treat Lung Cancer | unknown | Phase 2 | 60 | Shandong Cancer Hospital and InstituteOTHER | 1 | Jul 31, 2014 | clinicaltrials |
| NCT02002117 | Genotyping of Non-small Cell Lung Cancer | unknown | — | 100 | National Taiwan University HospitalOTHER | 1 | Jul 30, 2014 | clinicaltrials |
| NCT02202655 | Study of Changes of Lymphocyte Subsets in Chemotherapy Course of Patients With Non-small Cell Lung Cancer(NSCLC) | unknown | — | 50 | Beijing Chao Yang HospitalOTHER | 1 | Jul 29, 2014 | clinicaltrials |
| NCT01786122 | Clinical Trial: Effectiveness and Efficiency of Physical Exercise in Cancer Patients(EFICANCER) | unknown | N/A | 250 | Basque Health ServiceOTHER_GOV | 1 | Jul 23, 2014 | clinicaltrials |
| NCT02195076 | Non Invasive Detection of Lung and Breast Cancer by Odor Signature | unknown | — | 400 | BioSense Medical LTDINDUSTRY | 1 | Jul 21, 2014 | clinicaltrials |
| NCT02195336 | dMR During First Line Treatment of Non Squamous Lung Cancer: Time Course and Prognostic and Predictive Impact.(BevMar) | unknown | N/A | 20 | Karl KölbeckOTHER | 1 | Jul 21, 2014 | clinicaltrials |
| NCT02195453 | Chemotherapy Combined With Yangzhengxiaoji Capsule in Patients With Advanced Non-Small Cell Lung Cancer | unknown | Phase 4 | 520 | Shandong Cancer Hospital and InstituteOTHER | 0 | Jul 21, 2014 | clinicaltrials |
| NCT02121379 | Randomized Clinical Trial of 8 Weeks Pulmonary Rehabilitation in Advanced Stage Lung Cancer Patients With COPD During Cytotoxic Chemotherapy | unknown | N/A | 40 | Seoul National University HospitalOTHER | 1 | Jun 2, 2014 | clinicaltrials |
| NCT02146118 | A Phase II Study to Assess Efficacy of Combined Treatment With Erlotinib (Tarceva) and Silybin-phytosome (Siliphos) in Patients With EGFR Mutant Lung Adenocarcinoma | unknown | Phase 2 | 42 | MedicalLogicINDUSTRY | 1 | May 23, 2014 | clinicaltrials |
| NCT02139579 | Efficacy and Safety Study of Bevacizumab Plus Chemotherapy in EGFR-TKI Resistant Non-Squamous Non-Small Cell Lung Cancer | unknown | Phase 2 | 24 | Sun Yat-sen UniversityOTHER | 0 | May 15, 2014 | clinicaltrials |
| NCT01193829 | Development of Circulating Tumour Cell Molecular Diagnostics Using a Novel Microfluidic Device | unknown | — | 30 | National University Hospital, SingaporeOTHER | 1 | Apr 28, 2014 | clinicaltrials |
| NCT01969955 | Nab-paclitaxel as Second-line Therapy in Locally Advanced or Metastatic Squamous Lung Cancer | unknown | Phase 2 | 50 | Chinese Academy of Medical SciencesOTHER | 1 | Apr 25, 2014 | clinicaltrials |
| NCT02090166 | Lung Cancer Detection by Measuring Monocyte Activity(EDLC) | unknown | N/A | 950 | Carmel Medical CenterOTHER | 1 | Mar 18, 2014 | clinicaltrials |
| NCT02075957 | Identification by Microarrays of the Risks of Metastatic Relapse, Toxicity and Resistance to Adjuvant Chemotherapy in Completely Resected Non-small Cell Lung Cancer(SITRR) | unknown | — | 192 | University Hospital, AngersOTHER_GOV | 1 | Mar 3, 2014 | clinicaltrials |
| NCT01861223 | Afatinib Plus Nimotuzumb for NSCLC | unknown | Phase 1 / Phase 2 | 50 | Samsung Medical CenterOTHER | 1 | Feb 25, 2014 | clinicaltrials |
| NCT01852838 | The Contribution of Induced Glycolysis to the Exhaled Volatile Organic Compounds' (VOCs) Signature in Lung Cancer | unknown | — | 70 | Sheba Medical CenterOTHER_GOV | 1 | Feb 21, 2014 | clinicaltrials |
| NCT02066038 | Intermittent and Maintenance of Erlotinib in Combination With Pemetrexed/Carboplatin in Ⅲb/IV Non Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutation | unknown | Phase 2 | 60 | Sun Yat-sen UniversityOTHER | 0 | Feb 19, 2014 | clinicaltrials |
| NCT02058433 | Safety Study of Individual Paclitaxel Dose Adjustment Based on Pharmacokinetics in Non-Small Cell Lung Cancer (NSCLC) | unknown | Phase 3 | 140 | Caicun ZhouOTHER | 1 | Feb 10, 2014 | clinicaltrials |
| NCT01130571 | Establishment and Characterization of Patient-Derived Non-Small Cell Lung Cancer Xenografts and Cell Cultures | unknown | — | — | National University Hospital, SingaporeOTHER | 1 | Jan 22, 2014 | clinicaltrials |
| NCT02039518 | Study of Gemcitabine Maintenance Treatment in Patients With Extensive SCLC Patients | unknown | Phase 2 | 160 | Fudan UniversityOTHER | 1 | Jan 17, 2014 | clinicaltrials |
| NCT02036359 | Erlotinib Monotherapy Versus Docetaxel and Cisplatin as Neoadjuvant Therapy in Patients of stageIIIA Lung ca(Oncology) | unknown | Phase 2 | 76 | National Taiwan University HospitalOTHER | 1 | Jan 15, 2014 | clinicaltrials |
| NCT00717353 | Genetic Polymorphisms in UGT1A6 and UGT2B7 in Asian Population: Association With Lung Cancer Phenotype | unknown | — | — | National University Hospital, SingaporeOTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT00958555 | A Study of Predictive and Prognostic Markers in Patients With Non-small Cell Lung Cancer | unknown | — | — | National University Hospital, SingaporeOTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT01784185 | Virtual Bronchoscopy (VB) vs. Endobronchial Ultrasound (EBUS) Guided Mediastinal Sampling(VB/EBUS-TBNA) | unknown | N/A | 60 | Medical University of WarsawOTHER | 1 | Jan 13, 2014 | clinicaltrials |
| NCT00514293 | Bexarotene, Tretinoin, and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | unknown | Phase 2 | 39 | Raghu Nandan, M.D., IncOTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT00003284 | High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Lung Cancer | unknown | Phase 2 | 30 | Herbert Irving Comprehensive Cancer CenterOTHER | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00022243 | T138067 in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer That Has Not Responded to Previous Chemotherapy | unknown | Phase 2 | — | TularikINDUSTRY | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00030641 | Docetaxel With or Without Oblimersen in Treating Patients With Non-Small Cell Lung Cancer | unknown | Phase 2 / Phase 3 | — | Genta IncorporatedINDUSTRY | 3 | Jan 6, 2014 | clinicaltrials |
| NCT00033722 | Lometrexol Plus Folic Acid in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | unknown | Phase 2 | — | TularikINDUSTRY | 1 | Jan 6, 2014 | clinicaltrials |
| NCT01998061 | Continuation of TKI With or Without Chemotherapy Beyond Gradual Progression | unknown | Phase 2 | 20 | Zhejiang UniversityOTHER | 1 | Dec 20, 2013 | clinicaltrials |
| NCT02005120 | Intrapleural Administration of Bevacizumab Versus Endostar for Pleural Effusions in NSCLC | unknown | Phase 2 | 20 | Zhejiang UniversityOTHER | 1 | Dec 20, 2013 | clinicaltrials |
| NCT00003447 | Vinorelbine and/or Gemcitabine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer | unknown | Phase 3 | 630 | Istituto Nazionale per lo Studio e la Cura dei TumoriOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00006048 | ZD 1839 Plus Combination Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer | unknown | Phase 3 | — | AstraZenecaINDUSTRY | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00006049 | ZD 1839 Plus Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer | unknown | Phase 3 | — | AstraZenecaINDUSTRY | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00006215 | Docetaxel and Vinorelbine Plus Filgrastim in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | unknown | Phase 2 | — | AmgenINDUSTRY | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00021008 | ZD0473 in Treating Patients With Progressive or Relapsed Non-Small Lung Cancer | unknown | Phase 2 | — | Jonsson Comprehensive Cancer CenterOTHER | 0 | Dec 19, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Nov 20, 2014source: clinicaltrials